FDA Inspection
Mid-Continent Packaging, IncMid-Continent Packaging, Inc – FDA Inspection, Jan 24, 2013
Record Details
This FDA Inspection record concerns Mid-Continent Packaging, Inc, with an inspection on January 24, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Mid-Continent Packaging, Inc
- Inspection Date
- January 24, 2013
- Product Type
- Drugs
View Company Profile
ID · c53b771f-6357-4c8b-8402-faab7b13cd2e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 815531
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
12- 21 CFR 211.103Actual vs. theoretical yields not determined
- 21 CFR 211.188(b)(8)Labeling control records including specimens or copies
- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.184(c)Individual inventory record
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.170(b)Reserve samples identified, representative, stored
- 21 CFR 211.170(b)(1)Retention time of reserve samples, in general
- 21 CFR 211.186(a)Signature and checking of records -- 2 persons
- 21 CFR 211.100(a)Absence of Written Procedures
Showing 10 of 12 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mid-Continent Packaging, Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mid-Continent Packaging, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.